3AB2 image
Deposition Date 2009-11-30
Release Date 2010-06-23
Last Version Date 2023-11-01
Entry Detail
PDB ID:
3AB2
Keywords:
Title:
Crystal structure of aspartate kinase from Corynebacterium glutamicum in complex with threonine
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.59 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Aspartokinase
Gene (Uniprot):lysC
Chain IDs:A, C, E, G, I, K, M, O
Chain Length:421
Number of Molecules:8
Biological Source:Corynebacterium glutamicum
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Aspartokinase
Gene (Uniprot):lysC
Chain IDs:B, D, F, H, J, L, N, P
Chain Length:178
Number of Molecules:8
Biological Source:Corynebacterium glutamicum
Ligand Molecules
Primary Citation
Mechanism of concerted inhibition of {alpha}2{beta}2-type heterooligomeric aspartate kinase from Corynebacterium glutamicum
J.Biol.Chem. 285 27477 27486 (2010)
PMID: 20573952 DOI: 10.1074/jbc.M110.111153

Abstact

Aspartate kinase (AK) is the first and committed enzyme of the biosynthetic pathway producing aspartate family amino acids, lysine, threonine, and methionine. AK from Corynebacterium glutamicum (CgAK), a bacterium used for industrial fermentation of amino acids, including glutamate and lysine, is inhibited by lysine and threonine in a concerted manner. To elucidate the mechanism of this unique regulation in CgAK, we determined the crystal structures in several forms: an inhibitory form complexed with both lysine and threonine, an active form complexed with only threonine, and a feedback inhibition-resistant mutant (S301F) complexed with both lysine and threonine. CgAK has a characteristic alpha(2)beta(2)-type heterotetrameric structure made up of two alpha subunits and two beta subunits. Comparison of the crystal structures between inhibitory and active forms revealed that binding inhibitors causes a conformational change to a closed inhibitory form, and the interaction between the catalytic domain in the alpha subunit and beta subunit (regulatory subunit) is a key event for stabilizing the inhibitory form. This study shows not only the first crystal structures of alpha(2)beta(2)-type AK but also the mechanism of concerted inhibition in CgAK.

Legend

Protein

Chemical

Disease

Primary Citation of related structures